Category Innovation/ R&D

To Stem Infringement, Block Money – Not Information

The Protect IP Act, currently pending in the United States Senate, contains a range of steps designed to support the holders of American copyrights and trademarks by fighting a specific part of the online infringement problem: “rogue” websites whose primary or intended use is the infringement of US copyrights or trademarks. The bill would take promising new steps to diminish the financial rewards of IPR infringement - but it is saddled with ill-advised information blocking provisions that should, and probably will, be prevented from passing the Senate in its current form, writes David Robinson.

Recommendations For Navigating IP Terrain Emerge From UNITAID Forum

The third consultative forum of drug-purchasing mechanism UNITAID held in Geneva on 4-5 October resulted in a set of recommendations related to intellectual property rights and medicines access. The forum provided the opportunity for a wide array of global health actors, industry and country representatives to review the organisation’s progress in the last five years and to provide input on its future activities.

Medicines Patent Pool Signs Deal With Indian Generics Producer

The Medicines Patent Pool, which negotiates voluntary licences for lower pharmaceutical prices, today announced the signing of an agreement with generics producer Aurobindo Pharma Limited to manufacture antiretroviral medicines. The Patent Pool has recently come under criticism from AIDS activists concerned about its July licence agreement with drug company Gilead, and it remains to be seen if this action will address their concerns.

A Response From The Authors Of The Health Impact Fund

In reaction to the recent IP-Watch Inside Views post “Health Impact Fund – Raising Issues of Distribution, IP Rights and Alliances,” by Sakiko Fukuda-Parr and Proochista Ariana, the authors offer a response on behalf of Incentives for Global Health (IGH), the non-profit organization that is developing the Health Impact Fund (HIF) proposal.

US Patent Law Seen Opening Door To Global Harmonisation At WIPO

Just a week after US patent reform was signed into law, the Symposium of Intellectual Property Authorities opened with an air of celebration on 22 September at the World Intellectual Property Organization (WIPO). During the opening session, several keynote speakers congratulated United States Patent and Trademark Office Director David Kappos for the long-awaited legislation helping to harmonise the American patent process with the rest of the world.

A Call To Update Trade Policy Apps In The Internet Era

Access to the internet and internet services, such as Facebook, YouTube, and Twitter, is often thought about in terms of freedom of expression. The so-called Arab Spring reinforced that link as governments limited, censored and restricted the internet in an effort to control communication.

But freedom of information and open access to the internet is not only a human rights issue; it is also of vital importance to the world economy. This was the key message that emerged from “Blocking the Free Flow of Information: A New Trade Barrier,” a session held at the World Trade Organization’s Public Forum on 21 September.

Breakthrough Gives EU Principles For Digitising Out-Of-Print Books

Key European stakeholders have approved a "ground-breaking" set of principles for digitising and making publicly available out-of-print books and journals. The accord could serve as a template for dealing with the vexing problem of orphan works, those for whom the copyright owner cannot be found, according to International Federation of Reproduction Rights Organisations CEO Olav Stokkmo.

Questions Arise Over UN Policy On Non-Communicable Diseases And IP Rights

United Nations members this month are setting the future course for global action against a rising public health problem well-known in developed countries and spreading to developing countries: noncommunicable diseases. But whether they will – or should - address concerns that intellectual property rights issues might interfere with access to treatments for such diseases as diabetes, cancer, or heart disease remains to be seen.